Biblio

Found 28 results
Author Keyword Title [ Type(Desc)] Year
Filters: Author is Haines, Jonathan L  [Clear All Filters]
Journal Article
van der Walt JM, Dementieva YA, Martin ER, Scott WK, Nicodemus KK, Kroner CC, Welsh-Bohmer KA, Saunders AM, Roses AD, Small GW et al..  2004.  Analysis of European mitochondrial haplogroups with Alzheimer disease risk.. Neurosci Lett. 365(1):28-32.
Ghani M, Reitz C, Cheng R, Vardarajan BNarayan, Jun G, Sato C, Naj A, Rajbhandary R, San Wang L-, Valladares O et al..  2015.  Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals.. JAMA Neurol. 72(11):1313-23.
Allen M, Kachadoorian M, Quicksall Z, Zou F, Chai HSeng, Younkin C, Crook JE, V Pankratz S, Carrasquillo MM, Krishnan S et al..  2014.  Association of MAPT haplotypes with Alzheimer's disease risk and MAPT brain gene expression levels.. Alzheimers Res Ther. 6(4):39.
Zou F, Chai HSeng, Younkin CS, Allen M, Crook J, V Pankratz S, Carrasquillo MM, Rowley CN, Nair AA, Middha S et al..  2012.  Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants.. PLoS Genet. 8(6):e1002707.
Huang K-L, Marcora E, Pimenova AA, Di Narzo AF, Kapoor M, Jin SChih, Harari O, Bertelsen S, Fairfax BP, Czajkowski J et al..  2017.  A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease.. Nat Neurosci. 20(8):1052-1061.
Naj AC, Jun G, Beecham GW, San Wang L-, Vardarajan BNarayan, Buros J, Gallins PJ, Buxbaum JD, Jarvik GP, Crane PK et al..  2011.  Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.. Nat Genet. 43(5):436-41.
Nicodemus KK, Stenger JE, Schmechel DE, Welsh-Bohmer KA, Saunders AM, Roses AD, Gilbert JR, Vance JM, Haines JL, Pericak-Vance MA et al..  2004.  Comprehensive association analysis of APOE regulatory region polymorphisms in Alzheimer disease.. Neurogenetics. 5(4):201-8.
Naj AC, Beecham GW, Martin ER, Gallins PJ, Powell EH, Konidari I, Whitehead PL, Cai G, Haroutunian V, Scott WK et al..  2010.  Dementia revealed: novel chromosome 6 locus for late-onset Alzheimer disease provides genetic evidence for folate-pathway abnormalities.. PLoS Genet. 6(9):e1001130.
Naj AC, Jun G, Reitz C, Kunkle BW, Perry W, Park YSon, Beecham GW, Rajbhandary RA, Hamilton-Nelson KL, San Wang L- et al..  2014.  Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study.. JAMA Neurol. 71(11):1394-404.
Butkiewicz M, Blue EE, Leung YYee, Jian X, Marcora E, Renton AE, Kuzma A, San Wang L-, Koboldt DC, Haines JL et al..  2018.  Functional annotation of genomic variants in studies of late-onset Alzheimer's disease.. Bioinformatics. 34(16):2724-2731.
Desikan RS, Fan CChieh, Wang Y, Schork AJ, Cabral HJ, L Cupples A, Thompson WK, Besser L, Kukull WA, Holland D et al..  2017.  Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score.. PLoS Med. 14(3):e1002258.
Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A et al..  2019.  Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.. Nat Genet. 51(3):414-430.
Beecham GW, Hamilton K, Naj AC, Martin ER, Huentelman M, Myers AJ, Corneveaux JJ, Hardy J, Vonsattel J-P, Younkin SG et al..  2014.  Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias.. PLoS Genet. 10(9):e1004606.
Deming Y, Li Z, Kapoor M, Harari O, Del-Aguila JL, Black K, Carrell D, Cai Y, Fernández MVictoria, Budde J et al..  2017.  Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers.. Acta Neuropathol. 133(5):839-856.
Beecham GW, Martin ER, Li Y-J, Slifer MA, Gilbert JR, Haines JL, Pericak-Vance MA.  2009.  Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease.. Am J Hum Genet. 84(1):35-43.
Kunkle BW, Jaworski J, Barral S, Vardarajan B, Beecham GW, Martin ER, Cantwell LS, Partch A, Bird TD, Raskind WH et al..  2016.  Genome-wide linkage analyses of non-Hispanic white families identify novel loci for familial late-onset Alzheimer's disease.. Alzheimers Dement. 12(1):2-10.
Li Y-J, Oliveira SA, Xu P, Martin ER, Stenger JE, Scherzer CR, Hauser MA, Scott WK, Small GW, Nance MA et al..  2003.  Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease.. Hum Mol Genet. 12(24):3259-67.
Cruchaga C, Kauwe JSK, Harari O, Jin SChih, Cai Y, Karch CM, Benitez BA, Jeng AT, Skorupa T, Carrell D et al..  2013.  GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.. Neuron. 78(2):256-68.
Scott WK, Hauser ER, Schmechel DE, Welsh-Bohmer KA, Small GW, Roses AD, Saunders AM, Gilbert JR, Vance JM, Haines JL et al..  2003.  Ordered-subsets linkage analysis detects novel Alzheimer disease loci on chromosomes 2q34 and 15q22.. Am J Hum Genet. 73(5):1041-51.
Desikan RS, Schork AJ, Wang Y, Thompson WK, Dehghan A, Ridker PM, Chasman DI, McEvoy LK, Holland D, Chen C-H et al..  2015.  Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease.. Circulation. 131(23):2061-2069.
Sims R, van der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, Kunkle BW, Boland A, Raybould R, Bis JC et al..  2017.  Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.. Nat Genet. 49(9):1373-1384.
San Wang L-, Naj AC, Graham RR, Crane PK, Kunkle BW, Cruchaga C, Murcia JDGonzalez, Cannon-Albright L, Baldwin CT, Zetterberg H et al..  2015.  Rarity of the Alzheimer disease-protective APP A673T variant in the United States.. JAMA Neurol. 72(2):209-16.
Li Y-J, Scott WK, Zhang L, Lin P-I, Oliveira SA, Skelly T, Doraiswamy MP, Welsh-Bohmer KA, Martin ER, Haines JL et al..  2006.  Revealing the role of glutathione S-transferase omega in age-at-onset of Alzheimer and Parkinson diseases.. Neurobiol Aging. 27(8):1087-93.
Mez J, Chung J, Jun G, Kriegel J, Bourlas AP, Sherva R, Logue MW, Barnes LL, Bennett DA, Buxbaum JD et al..  2017.  Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.. Alzheimers Dement. 13(2):119-129.
Slifer MA, Martin ER, Haines JL, Pericak-Vance MA.  2005.  The ubiquilin 1 gene and Alzheimer's disease.. N Engl J Med. 352(26):2752-3;authorreply2752-3.